Current projects and activities

Accelerant projects

  • Project type: Proof of concept

    Project status: 10% complete

    Partners involved: TopMD, COVID-19 Disease Maps Group, CIAO Project

    Problem: How to identify and confirm AOPs of COVID-19 and Long COVID from single cell transcriptomics data as well as from gene expression, shedding light on the mechanistic and casual effects, together with personalised global pathway activity.

    Fit with vision: Use of precision medicine and AI to help diagnose and predict outcomes early and stratify patients for potential new therapeutics.

    Concept: Analyse differences and similarities of AOPs detected by COVID-19 Disease Maps and TopMD Maps and intertwine with the CIAO Project omics related AOPs.

    Successful outcome: Identification of biomarkers essential in highlighting key events of disease critical state evolution

    Next Steps: Publication, present outcome in a Spotlight Session and replicate exercise of other COVID AOPs.

  • Project type: Initiation

    Project status: 5% complete

    Partners involved: Radiomics, ERS END COVID CRC, CDISC, Thirona, ICL

    Problem: How adaptable is DistriM, a distributed machine learning solution, to set-up within the ERS CRC END COVID Registry for their research purposes.

    Fit with vision: Developing a learning health system.

    Concept: Assess END-COVID CRC needs against DistriM platform’s operational/technical solutions, data curation and model development needs for feasibility

    Successful outcome: Easy translation of DistriM to facilitate END-COVID CRC research questions

    Next Steps: Identify process and create feasibility outline, present outcome in a Spotlight Session, evaluate piloting DistriM in END COVID CRC sites.

Spotlight Sessions

Spotlight Sessions are the platform for members to present on any field relevant to their work - publication, new tool or technology, Accelerant Project under development, upcoming events, new initiatives.

Since May 2022 we had 3 Spotlight Sessions for members of the DRAGON Stakeholder Community, joined by nearly 100 participants.

Upcoming Spotlight Sessions

  • A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike

    Speaker: Daniel Hurdiss (IMI CARE, Utrecht University)

  • Long Covid Follow up: ERS Statement

    Speaker: Antonio Spanvello (Istituto Maugeri IRCCS Pavia)

    ELF Factsheets (title to be confirmed)

    Speaker: Pippa Powell, (ELF)

Want to learn more?

sapnasheth@biosciconsulting.com
(32) 89- 25 -4009

Belgium

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101005122. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. https://www.imi.europa.eu/